Health Canada approves Canswab for COVID-19 testing
Precision ADM

Health Canada approves Canswab for COVID-19 testing

Precision ADM expands operations to produce nasopharyngeal swabs.


Precision ADM, a global medical device company and advanced manufacturing solutions provider, has received Health Canada approval for its Canswab nasopharyngeal swabs.

The new 3D-printed swab’s collection capability has been clinically tested and proven statistically equivalent to a traditional flocked swab. Precision ADM has secured an additional 20,000ft2 facility in order to build the necessary cleanroom manufacturing areas for mass-producing nasopharyngeal swabs. With the added capabilities and facilities, the company will be able to manufacture and ship hundreds of thousands of Canswab nasopharyngeal swabs per week.

Precision ADM has received multiple Canswab orders from Canadian Provincial Governments, and with a letter of intent from the Federal Government of Canada, the company is scaling up production with the goal of producing 2 million to 4 million swabs per month to meet the needs of Canada and other countries.

“We have been manufacturing surgical products, such as spine devices and joint replacements, for a long time, but during this pandemic, we’ve taken steps to make sure we are doing all we can to support a secure domestic supply chain for our healthcare system in Canada,” says Martin Petrak, CEO of Precision ADM. “Adding additional 3D printing capacity to our operations will enable us to produce essential testing equipment in North America and help our communities faster.”

Precision ADM is the only additive manufacturing services company in Canada that possesses ISO 13485:2016 medical device manufacturing certification and has a facility that is FDA registered. The company possesses a Health Canada MDEL license for manufacturing and distribution of Class I medical devices.